Non-Hispanic African American women and Hispanic men treated with insulin and oral agents were disproportionately represented among those with poor glycemic control reported in a study using national survey data (9), possibly resulting in increased medical care costs for individuals with diabetes. The gene discussed is INS; the disease is diabetes mellitus.